Compared to patients with BMS , those treated with SES and EES had a strong trend towards lower two-year rates of the primary endpoint ( HR : @ -LSB- CI : @-@ @ -RSB- , p = @ , and HR : @ -LSB- CI : @-@ @ -RSB- , p = @ ) , and of TVR ( HR : @ -LSB- CI : @-@ @ -RSB- , p = @ ) and ( HR : @ -LSB- CI : @-@ @ -RSB- , p = @ ) .